Quick Hits

Welcome to Project CBD Quick Hits, where we collect some of the most interesting and informative tidbits of research into cannabis over the past week.

Safer Sex

Posted: February 11, 2019
Image of a lab technician at work

Much funding has been devoted to studying drug use and risky sexual practices. While this is a serious issue that should be addressed, such research has been misused to stigmatize marginalized groups. It is used to justify greater enforcement of racist drug laws in communities of color by insinuating that poor black women are misusing their autonomy, and hence need to be forced into rehabilitation programs for their own good. But even the premise may be wrong among cannabis users. Researchers in Los Angeles have recently shown that, among homosexual men, cannabis users are safer about sex and have dramatically lower rates of STIs compared with people not using illicit drugs or using other illegal drugs.

CBD vs. Methamphetamine

Posted: February 11, 2019

Little needs to be said about the devastating impact methamphetamine abuse can have. It is a highly addictive substance whose use can lead to transient psychotic behavior and long-term cognitive problems. As part of an Iranian researcher’s PhD thesis, two scientists demonstrate that CBD can reduce the likelihood of methamphetamine relapse, even while one deals with stresses like sleep deprivation. This is particularly important because drug withdrawal often causes temporary insomnia, yet many of the medications that induce sleep are highly addictive. The researchers injected CBD directly into rats’ brain and measured the conditioned place preference for meth - a common preclinical predictor of addiction and relapse - under different experimental conditions. The implications for humans are, of course, speculative as of now.

CBD and Autism

Posted: January 24, 2019
Image of a smiling young boy

In his first article of the new year, Raphael Mechoulam and other Israeli scientists look at the “real life experiences of medical cannabis treatment in autism.” Published in Nature, the study found that just under a third of patients report significant improvements and over half report moderate improvements while using CBD-rich oil derived from cannabis (30% CBD, 1-2% THC). The improvements include decreased aggression and agitation, fewer seizures, and better sleep, appetite and ability to concentrate. Around 10-20% of patients stopped taking various medications (mostly antipsychotic and antiepileptic drugs) within 6 months of starting cannabis treatment. One quarter of people experienced some negative side effects like sedation or restlessness, but none were severe. And about one in 5 stopped treatment because it wasn’t effective. Even though there remains a lot to be discovered about how and why CBD can improve the lives of people with autism, it is clear that cannabis can be used safely by this population and should be studied further.

Cannabinoid Crystals

Posted: January 24, 2019
Image of cannabinoid crystals

Across political boundaries, a group of scientists from Russia, China, and the USA crystallized the CB2 cannabinoid receptor. This is a major achievement that will deepen our understanding of how CB2 works at a chemical level, even though X-rays of the crystal don’t provide a perfect representation of CB2 as it exists in the body. Many of these scientists were also involved in crystallizing the other main cannabinoid receptor, CB1, in 2016. These developments are also a major help to those trying to design new drugs targeting cannabinoid receptors. To get a better sense of what “understanding” the chemical structure of the CB2 entails, see these articles on A lipid pathway for ligand binding is necessary for a cannabinoid G protein-coupled receptor and Structure-kinetic relationship studies of cannabinoid CB2 receptor agonists reveal substituent-specific lipophilic effects on residence time.

Concussions and Alcoholism

Posted: January 24, 2019

Traumatic brain injury (TBI) leads to numerous problems, including alcoholism and suicide. New findings indicate that endocannabinoids aid TBI recovery: When researchers boosted 2-AG levels shortly after injury, rats displayed less anxiety and less interest in alcohol. This is significant since alcoholism is a serious comorbidity of brain injury. The researchers link the protective effect of 2-AG to changes in glutamate transmission in the central amygdala, the part of the brain that processes traumatic and fearful memories. Other preclinical research has demonstrated that endocannabinoids can play a protective role after traumatic brain injuries, like concussion, by ameliorating glutamatergic toxicity.

Self-Medicating for Endometriosis

Posted: January 24, 2019
Image illustrating a woman with abdominal pain

Endometriosis is a poorly-understood condition causing severe chronic pain and alterations in a woman’s menstrual cycle. As an understudied disease, treatment is limited. Scientists surveyed over 400 Australian women to see what actions they took to treat their pelvic pain. Cannabis, heat, CBD oil, and dietary changes were rated most effective by women, in that order. Unfortunately, more women used alcohol than cannabis to manage symptoms; self-medicating with alcohol promotes chronic inflammation and led to worsening pain and fatigue in over half of such women. This underscores the importance of not treating cannabis like alcohol in the ongoing saga of legalization. (Note: endometriosis is diagnosed with an invasive surgical procedure, and so many women who likely have endometriosis go undiagnosed. The group that responded to this survey had a confirmed diagnosis.)

Cannabis and ADHD

Posted: January 24, 2019
Abstract illustration of a person viewing into a mind

A study in Molecular Psychiatry with tens of thousands of people found an association between ADHD and cannabis use. Their data suggests that ADHD causes later cannabis use, which may support the notion that THC is used to self medicate (although ADHD is associated with heavier use of many drugs). Previous research has found that THC may be effective for some cases that do not respond well to Ritalin.